Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Ambiq Micro, Inc.NYSE: AMBQ
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables rises 170.6% from a year ago
Net receivables stood at $10.98M at the end of Q1 FY2026, up 170.6% from a year earlier and up 50.6% from the prior quarter.
Context
- Net receivables amounted to 4.2% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
- Net receivables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +170.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 7.29M USD
- Year-over-year change
- -29.9%
- 5-year CAGR
- -7.9%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.29M | -29.9% |
| FY2024 | 2024-12-31 | 10.4M | -15.3% |
| FY2023 | 2023-12-31 | 12.28M | — |
| FY2021 | 2021-12-31 | 20.69M | +88.2% |
| FY2020 | 2020-12-31 | 11M | — |
Net Receivables vs competitors
How AMBQ compares with its peers on the latest reported figures
- AMBQ's Mar 2026 net receivables of $10.98M is the 7th highest of the 11 companies compared; the peer median is $15.71M.
- Its year-over-year change of +170.6% is the 2nd highest of 11, against a peer median of +16.1%.
- Net receivables amounts to 4.2% of total assets for AMBQ, versus a peer median of 4.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $173.7M | -77.8% | +44.2% | 5.5% | |
| Mar 2026 | $63.61M | -2.2% | +9.4% | 10.3% | |
| Apr 2026 | $50.47M | +14.9% | +2.7% | 25.7% | |
| Sep 2026 | $39.69M | +17.3% | -2.8% | 3.3% | |
| Mar 2026 | $16.73M | +1559.4% | +159.1% | 23.6% | |
| Mar 2026 | $14.69M | +43.1% | +34.3% | 10.5% | |
AMBQAmbiq Micro, Inc. | Mar 2026 | $10.98M | +170.6% | — | 4.2% |
| Mar 2026 | $4.64M | +48.1% | +9.7% | 2.3% | |
| Mar 2026 | $4.26M | +140.7% | +35.7% | 2.2% | |
| Mar 2026 | $290.37K | -77.6% | +3.0% | 0.1% | |
NBPNovaBridge Biosciences | Dec 2025 | $256.33K | -97.0% | -62.4% | 0.7% |
| Peer median (excluding AMBQ) | $15.71M | +16.1% | +9.5% | 4.4% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 65.05M | 25.92M | 27.32M | 60.98M | 140.28M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 11M | 20.69M | 12.28M | 10.4M | 7.29M |
| Inventory | 7.44M | 33.68M | 21.48M | 15.01M | 16.94M |
| Other Current Assets | 803K | 2.01M | 2.79M | 2.57M | 2.82M |
| Total Current Assets | 94.79M | 98.84M | 63.86M | 88.96M | 167.32M |
| Property, Plant & Equipment (Net) | 3.2M | 5.49M | 2.97M | 3.54M | 4.78M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.62M | 700K | 5.56M | 11.73M | 11.59M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 81K | 96K | 40K | 49K | 993K |
| Total Non-current Assets | 4.9M | 6.29M | 8.57M | 15.32M | 17.36M |
| Total Assets | 99.68M | 105.13M | 72.43M | 104.28M | 184.68M |
| Account Payables | 2.82M | 11.04M | 2.41M | 2.93M | 8.58M |
| Short-term Debt | 0 | 0 | 0 | 0 | 400K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15K | 34K | 1.55M | 1.7M | 7.4M |
| Total Current Liabilities | 6.08M | 14.8M | 12.92M | 11.77M | 19.18M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.3M | 1.32M | 163K | 6.43M | 2.76M |
| Total Non-current Liabilities | 1.3M | 1.32M | 382K | 6.76M | 3.04M |
| Total Liabilities | 7.38M | 16.12M | 13.3M | 18.53M | 22.22M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (132.76M) | (158.1M) | (277.87M) | (320.25M) | (356.71M) |
| Accumulated OCI | 24K | 200K | (839K) | (520K) | (440K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 92.3M | 89.01M | 59.13M | 85.75M | 162.46M |
| Total Debt | 0 | 0 | 1.02M | 966K | 678K |
| Net Debt | (65.05M) | (25.92M) | (26.3M) | (60.02M) | (139.6M) |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.